Home LiteratureArticle Details
PMID: 16238546 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Effect of chronic N-acetylcysteine treatment on the development of spontaneous hypertension.

Clinical science (London, England : 1979) ·Vol. 110 ·No. 2 ·2006-02-00 ·Pages 235-42

Pechánová O, Zicha J, Kojsová S, Dobesová Z, Jendeková L, Kunes J

Abstract

The imbalance between NO (nitric oxide) and ROS (reactive oxygen species) is an important factor in the development of hypertension. The aim of the present study was to determine the preventive and therapeutic effects of NAC (N-acetylcysteine) in SHRs (spontaneously hypertensive rats). Young and adult SHRs and WKY (Wistar-Kyoto) rats were treated with NAC (20 g/l in the drinking water). After 8 weeks of treatment, BP (blood pressure) and NOS (NO synthase) activity, conjugated dienes and GSH (reduced glutathione) in the kidney and left ventricle were determined. Protein expression of eNOS (endothelial NOS), inducible NOS and NF-kappaB (nuclear factor kappaB) were also determined in the left ventricle and kidney. Chronic NAC treatment partially attenuated the rise in BP in young SHRs (179+/-6 compared with 210+/-8 mmHg in untreated animals), but it had no significant effect on BP in adult SHRs. The antioxidant action of NAC, measured as a decrease of the concentration of conjugated dienes or inhibition of NF-kappaB expression, was greater in young than in adult SHRs. Similarly, eNOS protein expression was attenuated more in young than in adult SHRs, although NAC treatment increased NOS activity to a similar extent in both young and adult rats. In conclusion, both decreased ROS production and increased NOS activity appear to participate in the BP changes after NAC treatment in young SHRs. In adult SHRs with established hypertension, however, the secondary alterations (such as pronounced structural remodelling of resistance vessels) might attenuate the therapeutic effect of NAC.

MeSH Terms
Acetylcysteine/therapeutic use Aging Animals Antioxidants/therapeutic use Glutathione/metabolism Heart Ventricles/metabolism Hypertension/drug therapy,metabolism Kidney/metabolism Male NF-kappa B/analysis Nitric Oxide Synthase/metabolism Nitric Oxide Synthase Type II/analysis Nitric Oxide Synthase Type III/analysis Random Allocation Rats Rats, Inbred SHR Rats, Inbred WKY Reactive Oxygen Species/metabolism
Chemicals
Antioxidants NF-kappa B Reactive Oxygen Species Nitric Oxide Synthase Nitric Oxide Synthase Type II Nitric Oxide Synthase Type III Glutathione Acetylcysteine
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Pechánová Olga
Institute of Normal and Pathological Physiology, Slovak Academy of Sciences, Sienkiewiczova 1, 813 71 Bratislava, Slovak Republic. olga.pechanova@savba.sk
Zicha Josef
Kojsová Stanislava
Dobesová Zdenka
Jendeková Lýdia
Kunes Jaroslav
Article Info
Journal
Clinical science (London, England : 1979)
Abbr.
Clin Sci (Lond)
ISSN
0143-5221
Published
2006-02-00
Pages
235-42
Language
English
Region
England
NLM ID
7905731
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com